Idorsia Ltd (IDIA.SW)
CHF 1.3
(2.45%)
CHF 1.3
(2.45%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 1.05 Billion CHF | -2.11% |
| 2022 | 1.08 Billion CHF | 1.81% |
| 2021 | 1.06 Billion CHF | 113.63% |
| 2020 | 497.17 Million CHF | 34.99% |
| 2019 | 368.31 Million CHF | 261.74% |
| 2018 | -227.71 Million CHF | 11.66% |
| 2017 | -257.76 Million CHF | 40.68% |
| 2016 | -434.55 Million CHF | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 1.02 Billion CHF | 10.97% |
| 2024 Q1 | 926.47 Million CHF | -12.48% |
| 2024 Q3 | 884.55 Million CHF | 13.54% |
| 2023 Q3 | 1 Billion CHF | -16.95% |
| 2023 Q4 | 1.05 Billion CHF | 5.85% |
| 2023 FY | 1.05 Billion CHF | -2.11% |
| 2023 Q1 | 1.01 Billion CHF | -6.29% |
| 2023 Q2 | 1.2 Billion CHF | 18.83% |
| 2022 Q2 | 969.2 Million CHF | -7.89% |
| 2022 Q4 | 1.08 Billion CHF | 22.1% |
| 2022 FY | 1.08 Billion CHF | 1.81% |
| 2022 Q1 | 1.05 Billion CHF | -0.93% |
| 2022 Q3 | 885.61 Million CHF | -8.62% |
| 2021 Q1 | 510.17 Million CHF | 2.61% |
| 2021 FY | 1.06 Billion CHF | 113.63% |
| 2021 Q4 | 1.06 Billion CHF | -6.28% |
| 2021 Q3 | 1.13 Billion CHF | 138.6% |
| 2021 Q2 | 474.96 Million CHF | -6.9% |
| 2020 FY | 497.17 Million CHF | 34.99% |
| 2020 Q1 | 537.03 Million CHF | 45.81% |
| 2020 Q2 | 251.9 Million CHF | -53.09% |
| 2020 Q3 | 485.82 Million CHF | 92.86% |
| 2020 Q4 | 497.17 Million CHF | 2.34% |
| 2019 Q2 | 163.6 Million CHF | 274.57% |
| 2019 FY | 368.31 Million CHF | 261.74% |
| 2019 Q4 | 368.31 Million CHF | 49.4% |
| 2019 Q1 | -93.71 Million CHF | 58.84% |
| 2019 Q3 | 246.53 Million CHF | 50.69% |
| 2018 Q1 | -182.36 Million CHF | 29.25% |
| 2018 FY | -227.71 Million CHF | 11.66% |
| 2018 Q3 | -101.82 Million CHF | 58.62% |
| 2018 Q2 | -246.05 Million CHF | -34.93% |
| 2018 Q4 | -227.71 Million CHF | -123.63% |
| 2017 Q1 | -330.43 Million CHF | 0.0% |
| 2017 FY | -257.76 Million CHF | 40.68% |
| 2017 Q4 | -257.76 Million CHF | -36.52% |
| 2017 Q3 | -188.8 Million CHF | 23.28% |
| 2017 Q2 | -246.1 Million CHF | 25.52% |
| 2016 FY | -434.55 Million CHF | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Addex Therapeutics Ltd | -3.52 Million CHF | 30163.346% |
| BB Biotech AG | 304.39 Million CHF | -247.759% |
| Basilea Pharmaceutica AG | 116.11 Million CHF | -811.644% |
| Evolva Holding SA | -5.83 Million CHF | 18230.303% |
| Kuros Biosciences AG | -8.69 Million CHF | 12281.519% |
| Molecular Partners AG | -183.23 Million CHF | 677.708% |
| Relief Therapeutics Holding AG | -10.24 Million CHF | 10432.592% |
| Santhera Pharmaceuticals Holding AG | -5.3 Million CHF | 20042.992% |